Agilent Technologies, Inc. (NYSE: A) has announced that it has signed a definitive agreement to acquire privately held Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) solutions for fully automated analysis of a range of molecules for USD 250 million in cash, the company said.
This acquisition will enhance Agilent´s existing expertise and technology, while giving customers a more comprehensive set of solutions.
Automated electrophoresis is a commonly used separation technique to analyze biomolecules such as nucleic acids (RNA and DNA), proteins, carbohydrates and small molecules. It has a broad range of applications and is used across a variety of industries segments including pharma and biopharma, academia and government, clinical and diagnostics, food, environmental and forensics, and chemical and energy.
Founded in 1998, AATI is based in Ankeny, Iowa and employs 101 employees.
The transaction is subject to customary closing conditions and regulatory approval.
Agilent Technologies is a global provider of life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers´ most challenging questions. The company generated revenues of USD 4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at www.agilent.com.